Sg Americas Securities, LLC Sarepta Therapeutics, Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 7,193 shares of SRPT stock, worth $751,956. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,193

Previous 12,062 40.37%

Holding current value

$751,956

Previous $1.91 Million 52.89%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	SELL	$124.33 - $156.75 $605,362 - $763,215	-4,869 Reduced 40.37%	7,193 $898,000
Q2 2024 Jul 12, 2024	BUY	$113.33 - $163.85 $786,850 - $1.14 Million	6,943 Added 135.63%	12,062 $1.91 Million
Q1 2024 May 06, 2024	BUY	$93.7 - $141.53 $479,650 - $724,492	5,119 New	5,119 $663,000
Q1 2023 Apr 28, 2023	BUY	$117.53 - $155.99 $769,116 - $1.02 Million	6,544 Added 86.11%	14,144 $1.95 Million
Q4 2022 Feb 02, 2023	BUY	$100.86 - $132.13 $766,536 - $1 Million	7,600 New	7,600 $985,000
Q2 2022 Jul 29, 2022	BUY	$62.69 - $88.44 $1.84 Million - $2.6 Million	29,396 Added 135.67%	51,064 $3.83 Million
Q1 2022 Apr 29, 2022	BUY	$63.15 - $90.42 $1.37 Million - $1.96 Million	21,668 New	21,668 $1.69 Million
Q4 2021 Feb 07, 2022	SELL	$77.28 - $99.42 $234,312 - $301,441	-3,032 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$65.97 - $92.48 $358,480 - $502,536	-5,434 Reduced 64.19%	3,032 $280,000
Q2 2021 Aug 12, 2021	SELL	$69.38 - $86.75 $593,337 - $741,886	-8,552 Reduced 50.25%	8,466 $658,000
Q1 2021 May 13, 2021	BUY	$72.25 - $168.95 $682,618 - $1.6 Million	9,448 Added 124.81%	17,018 $1.27 Million
Q4 2020 Feb 04, 2021	SELL	$125.56 - $178.74 $3.13 Million - $4.45 Million	-24,901 Reduced 76.69%	7,570 $1.29 Million
Q3 2020 Nov 09, 2020	BUY	$127.12 - $172.34 $3.5 Million - $4.74 Million	27,509 Added 554.39%	32,471 $4.56 Million
Q2 2020 Jul 20, 2020	SELL	$93.0 - $171.7 $4.03 Million - $7.44 Million	-43,303 Reduced 89.72%	4,962 $796,000
Q1 2020 Apr 30, 2020	BUY	$82.38 - $131.64 $3.98 Million - $6.35 Million	48,265 New	48,265 $4.72 Million
Q4 2019 Jan 28, 2020	SELL	$76.53 - $135.58 $184,590 - $327,018	-2,412 Closed	0 $0
Q3 2019 Nov 04, 2019	BUY	$72.81 - $156.91 $68,659 - $147,966	943 Added 64.19%	2,412 $182,000
Q2 2019 Jul 29, 2019	SELL	$112.21 - $151.95 $453,552 - $614,181	-4,042 Reduced 73.34%	1,469 $223,000
Q1 2019 Apr 29, 2019	BUY	$106.67 - $151.68 $59,841 - $85,092	561 Added 11.33%	5,511 $657,000
Q4 2018 Feb 01, 2019	BUY	$97.32 - $148.76 $335,851 - $513,370	3,451 Added 230.22%	4,950 $540,000
Q3 2018 Nov 06, 2018	BUY	$115.31 - $161.51 $172,849 - $242,103	1,499 New	1,499 $242,000
Q2 2018 Aug 07, 2018	SELL	$71.74 - $153.69 $314,651 - $674,084	-4,386 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$54.02 - $82.27 $105,447 - $160,591	1,952 Added 80.2%	4,386 $325,000
Q4 2017 Jan 24, 2018	SELL	$47.64 - $56.75 $279,456 - $332,895	-5,866 Reduced 70.67%	2,434 $135,000
Q3 2017 Nov 07, 2017	BUY	$35.73 - $47.15 $296,559 - $391,345	8,300	8,300 $376,000

Others Institutions Holding SRPT

# of Institutions

532

Shares Held

84.5M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.15B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Sarepta Therapeutics, Inc. Transaction History